U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07410988) titled 'Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications' on Jan. 18.
Brief Summary: This trial aims to compare two intraoperative fluids, namely hydroxyethyl starch (HES) and balanced crystalloids in terms of major adverse kidney events after cardiac surgery. Indications for the study fluids administarion include preload augmentation and intravascular volume replacement during cardiac surgery.
Study Start Date: May 01, 2026
Study Type: INTERVENTIONAL
Condition:
Cardiac Surgery
Intervention:
DRUG: Volulyte(R) (6% HES 130/0.4 in balanced solution)
Hydroxyethyl starch is used (up to 20 mL/kg) ...